ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselRegeneron Switzerland GmbH
Regeneron Switzerland GmbH Logo
Verified· 2 sources

Regeneron Switzerland GmbH

Summary

About the company

Regeneron Switzerland GmbH is a biopharmaceutical company that researches, develops, and commercializes medicines, including biologics and genetic medicines. It conducts clinical trials and maintains research and manufacturing activities to support its drug development pipeline.

AI-generated
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
✓ Offered12
Prescription biopharmaceuticals
Regeneron-invented approved medicines for serious diseases across allergy, inflammation, cardiovascular and metabolic disease, neuroscience, oncology, ophthalmology and rare diseases; available in the U.S., Europe, Japan and worldwide.
Clinical development and drug pipeline
Development of investigational medicines through clinical testing, including early- to late-stage programs in multiple therapeutic areas and full clinical development processes.
Research and development
Data-driven research and development using genetics, biology and technology to discover new drug candidates, validate targets and pursue biologics, genetic medicines and cell therapies.
Antibody medicines
Discovery and development of monoclonal, bispecific and costimulatory antibodies, supported by proprietary antibody technologies and engineering capabilities.
Genetic medicines
Gene editing, gene silencing and gene therapy approaches developed as part of the company’s therapeutic toolbox and pipeline.
Cell therapies
Development of next-generation cell therapies, including T-cell-based approaches and combinations with proprietary antibodies and bispecifics.
Manufacturing of medicines
Manufacturing of investigational and approved medicines at scale, including process development, production for clinical trials and commercial supply.
Business development partnerships
Strategic collaborations, licensing agreements and development partnerships for technologies, therapeutic candidates, clinical collaborations and commercial activities.
Third-party research collaborations
Access to approved and pipeline medicines, proprietary models and technologies for preclinical studies, investigator-initiated studies and research collaborations.
Grants and funding
Corporate funding, educational grants, sponsorships, exhibits and support for nonprofit, medical, STEM and community organizations.
Regeneron Genetics Center
Large-scale human genomics research and genetic databases to understand genetic drivers of human health and disease and support target discovery.
Clinical trials
Clinical trials for investigational products, including study information and trial locator access for patients, caregivers and healthcare professionals.
Comparisons

Regeneron Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Regeneron Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Regeneron Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grosspeteranlage 29
4052 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-426.698.987
Founded
2023 · 3 years
Last commercial register change
September 1, 2026
Employees
1 to 10

Knowledge

No knowledge articles yet

Once Regeneron Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

LT
LifeMine Therapeutics (Switzerland) GmbH
Basel
HM
Heart-Based Medicine Foundation
Basel
AB
Amyra Biotech AG
Basel
US
Urovant Sciences GmbH
Basel
VT
Vaderis Therapeutics AG
Basel
AA
ARTIDIS AG
Basel
FM
Friedrich Miescher Institute for Biomedical Research
Basel
NA
NBE-Therapeutics AG
Basel